These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7514786)

  • 21. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.
    Ding J; Das K; Hsiou Y; Sarafianos SG; Clark AD; Jacobo-Molina A; Tantillo C; Hughes SH; Arnold E
    J Mol Biol; 1998 Dec; 284(4):1095-111. PubMed ID: 9837729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of RNA template to a complex of HIV-1 reverse transcriptase/primer/template.
    Canard B; Sarfati R; Richardson CC
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11279-84. PubMed ID: 9326600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Template. Phosphorothioate oligonucleotides duplexes as inhibitors of HIV-1 reverse transcriptase.
    Maury G; el Alaoui A; Morvan F; Müller B; Imbach JL; Goody RS
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1249-56. PubMed ID: 1380799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 1. Phthalimidoalkyl and -alkylamino analogues.
    Hoffman JM; Wai JS; Thomas CM; Levin RB; O'Brien JA; Goldman ME
    J Med Chem; 1992 Oct; 35(21):3784-91. PubMed ID: 1279172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing.
    Driscoll MD; Golinelli MP; Hughes SH
    J Virol; 2001 Jan; 75(2):672-86. PubMed ID: 11134281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
    Balani SK; Kauffman LR; Arison BH; Olah TV; Goldman ME; Varga SL; O'Brien JA; Ramjit HG; Rooney CS; Hoffman JM
    Drug Metab Dispos; 1994; 22(2):200-5. PubMed ID: 7516852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of donor and acceptor RNA structures on the mechanism of strand transfer by HIV-1 reverse transcriptase.
    Hanson MN; Balakrishnan M; Roques BP; Bambara RA
    J Mol Biol; 2005 Nov; 353(4):772-87. PubMed ID: 16216274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase.
    Moore PS; Jones CJ; Mahmood N; Evans IG; Goff M; Cooper R; Hay AJ
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):129-34. PubMed ID: 7536411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory potency of R-region specific antisense oligonucleotides against in vitro DNA polymerization and template-switching reactions catalysed by HIV-1 reverse transcriptase.
    Borkow G; Arion D; Noronha A; Scartozzi M; Damha MJ; Parniak MA
    Int J Biochem Cell Biol; 1997 Nov; 29(11):1285-95. PubMed ID: 9451826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
    Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW
    J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains.
    Li A; Ouyang Y; Wang Z; Cao Y; Liu X; Ran L; Li C; Li L; Zhang L; Qiao K; Xu W; Huang Y; Zhang Z; Tian C; Liu Z; Jiang S; Shao Y; Du Y; Ma L; Wang X; Liu J
    J Med Chem; 2013 May; 56(9):3593-608. PubMed ID: 23540737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of 2-pyridinone derivatives as specific HIV-1 reverse transcriptase inhibitors. 3. Pyridyl and phenyl analogs of 3-aminopyridin-2(1H)-one.
    Wai JS; Williams TM; Bamberger DL; Fisher TE; Hoffman JM; Hudcosky RJ; MacTough SC; Rooney CS; Saari WS; Thomas CM
    J Med Chem; 1993 Jan; 36(2):249-55. PubMed ID: 7678654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription.
    Lee R; Kaushik N; Modak MJ; Vinayak R; Pandey VN
    Biochemistry; 1998 Jan; 37(3):900-10. PubMed ID: 9454580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase.
    Feng JY; Anderson KS
    Biochemistry; 1999 Jan; 38(1):55-63. PubMed ID: 9890882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplex.
    Freund F; Boulmé F; Litvak S; Tarrago-Litvak L
    Nucleic Acids Res; 2001 Jul; 29(13):2757-65. PubMed ID: 11433020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Column-switching high-performance liquid chromatographic determination of a 2-pyridinone-based human immunodeficiency virus type 1 (HIV-1)-specific reverse transcriptase inhibitor in human plasma.
    Woolf EJ; Matuszewski BK
    Pharm Res; 1993 Jan; 10(1):56-60. PubMed ID: 7679213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.
    Beerens N; Groot F; Berkhout B
    Nucleic Acids Res; 2000 Nov; 28(21):4130-7. PubMed ID: 11058109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.
    Balani SK; Pitzenberger SM; Kauffman LR; Arison BH; Ramjit HG; Goldman ME; O'Brien JA; King JD; Hoffman JM; Rooney CS
    Drug Metab Dispos; 1992; 20(6):869-76. PubMed ID: 1283569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants.
    Kleim JP; Rösner M; Winkler I; Paessens A; Kirsch R; Hsiou Y; Arnold E; Riess G
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):34-8. PubMed ID: 8552634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.
    Medina-Franco JL; Rodríguez-Morales S; Juárez-Gordiano C; Hernández-Campos A; Jiménez-Barbero J; Castillo R
    Bioorg Med Chem; 2004 Dec; 12(23):6085-95. PubMed ID: 15519154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.